Home > Insider Trading > Filing (0001209191-16-124062)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1518733	M Douglas Oort Van	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Chairman And Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-05-25	600,000	$1.71	2,275,000	No	4	M	Direct
Common Stock	Disposition	2016-05-25	118,613	$8.65	2,156,387	No	4	F	Direct
Common Stock	Disposition	2016-05-26	98,387	$8.69	2,058,000	No	4	S	Direct
Common Stock	Disposition	2016-05-27	383,000	$8.74	1,675,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2016-05-25	600,000	$1.71	600,000	$1.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200,000	2013-02-14	2017-02-14	No	4	X	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	187,500	Indirect	Conundrum Capital Partners
Common Stock	1,675,000	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy	$7.15	2017-04-20	2021-04-20	472,527	472,527	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-20	472,527	472,527	Direct

Footnotes

Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of ConundrumCapital Partners, LLC.
Shares withheld by NeoGenomics Inc. to satisfy the cost of the shares in connection with the May 25, 2016 stock option exercise.
Closing stock price on date of exercise, May 25, 2016.
Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. VanOort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date. On May 25, 2016. Mr. VanOort exercised 600,000 of these options leaving a balance of 200,000 options.